Li Chen

Li Chen

Auto-generated profile, based on publicly available information

Li Chen

Fujian Provincial Maternity and Child Health, Affiliated Hospital of Fujian Medical University

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Medicine
Verified
Journal Article
Open access
CCChong-Qing Cheng
Chong-Qing Cheng
RZRuitao Zhang
Ruitao Zhang
YXYu Xiong
Yu Xiong
LCLi Chen
Li Chen
JWJian Wang
Jian Wang
JBJin Bai
Jin Bai
As a noninvasive treatment technique, ultrasound-guided high-intensity focused ultrasound (HIFU) has been considered as a routine treatment for uterine fibroids and adenomyosis in China. Contrast-enhanced ultrasound (CEUS) has been proposed as another option to assess the treatment efficacy during HIFU treatment. The aim of this investigation is to evaluate the adverse effects of HIFU ablation for benign uterine diseases in a group of patients studied with ultrasound contrast agent (UCA), in comparison with a group of patients not exposed to UCA. From November 2010 to December 2013, 2604 patients with benign uterine diseases were treated with HIFU. Among them, 1300 patients were exposed to an UCA, whereas 1304 patients were not. During HIFU procedure, the incidences of leg pain, sacral/buttock pain, groin pain, treatment area pain, and the discomfort “hot” sensation on skin were higher in the patients who were exposed to SonoVue (Bracco, Milan, Italy) than those who were not (20.5% vs 11.7%, 52.5% vs 42.3%, 6.5% vs 4.5%, 68.9% vs 55.4%, and 48.1% vs 42.9%, respectively). Among the postoperative adverse effects, the incidence of lower abdominal pain was significantly higher in patients who were exposed to an UCA than those who were not (51.2% vs 39.9%, P < 0.05). Two patients who were exposed to an UCA had acute renal function failure. In conclusion, UCA may increase the incidences of some common HIFU-related adverse effects during HIFU treatment for benign uterine diseases, but most of which were acceptable and self-limited. After HIFU treatment, renal function should be monitored in patients with a history of hypertension or taking nonsteroidal anti-inflammatory drugs.

4 August 2021 in Research Square
Verified
Preprint
Open access
PDF file
YLYingying Lin
Yingying Lin
ZCZhiwei Chen
Zhiwei Chen
JHJianping Huang
Jianping Huang
JFJiaoning Fang
Jiaoning Fang
YQYuanjie Qi
Yuanjie Qi
HLHua Li
Hua Li
Background: Endometriosis (EMT) is the most common benign gynecological disease among women of reproductive age, causing infertility and seriously affects women's physical and mental health. However, the current treatment was not always effective. This study was designed to use publicly available data to identify drugs targeting the relevant gene with EMT-induced-infertility using computational tools.Methods: EMT and infertility genes were determined by text mining, and the GeneCodis program was used to analyzed gene ontology of the intersection of the two gene sets. A string database was used to analyze the protein-protein interaction network. The Drug-Gene Interaction database is queried for the rich gene set belonging to the identified pathways to find drug candidates that can be used in EMT-induced infertility.Results: Our analysis identified 550 genes common to both the EMT and infertility by text mining. Gene enrichment analysis and protein-protein interaction analysis found 39 genes potentially targetable by a total of 49 drugs that could be formulated for application, which have not been used in EMT-induced infertility. Conclusions: The findings from the present analysis can facilitate the Identification of existing drugs that have the potential of topical administration to improve EMT-induced infertility and present tremendous opportunities to study novel targets pharmacology using in silico text mining and pathway analysis tools.

19 August 2021 in Research Square
Verified
Preprint
Open access
PDF file
ZCZhiwei Chen
Zhiwei Chen
LHLingna Huang
Lingna Huang
LCLihua Chen
Lihua Chen
YQYuanjie Qi
Yuanjie Qi
LXLi Xie
Li Xie
GLGuolin Lu
Guolin Lu
Background: Labor epidural anesthesia-associated fever(LEAF) is the biggest problem for labor epidural anesthesia. This study aimed to evaluate the clinical value of serum magnesium levels to predict the LEAF.Methods: Finally, overall 528 singleton term-pregnant women who underwent labor epidural anesthesia in Fujian Provincial Maternity and Children's Health Hospital, affiliated hospital of Fujian Medical University from January 2019 to June 2019, were analyzed retrospectively. Using venous blood samples, the serum magnesium level was detected. The relationship between the serum magnesium level and LEAF was interpreted, and the optimal cut-off values of the serum magnesium level to predict LEAF were calculated. Results: Overall, 65(12.30%)participants had LEAF. And a higher rate of the bulging membrane, gestational hypertension, NICU admission, and the different mode of delivery was significantly associated with LEAF. Also, the serum magnesium level demonstrated higher significantly in LEAF presence than absence (p<0.05). What is more, it indicated that the area under the receiver operating characteristic curve (AUC) for the serum magnesium level was 0.825, and an optimal cut-off of the serum magnesium level was 0.855 mg/dl. Furthermore, it demonstrated that the serum magnesium level had the highest OR (OR= 7.49; 95% CI (4.58-14.35) ). The bulging membrane is an independent risk factor LEAF presence (OR = 1.55; 95% CI (1.01-2.43 ).Conclusions: Serum magnesium may reduce the incidence of LEAF. Serum magnesium can provide a suitable biomarker to predict LEAF and offer a useful target for LEAF treatment.